A group of researchers is urging NIH to create a public database of single nucleotide polymorphia or "snips," .genome markers that are Becoming hot commercial property. On 28 July, Abbott Laboratories of Abbott Park, Illinois, announced that it had entered into a deal with the genomics company Genset of Paris. The sum involved was relatively modest, but it sent a tremor through the academic genome" community. Many saw it as evidence that a powerful new tool for pinpointing genes involved in multigene diseases was about to be locked up behind patent claims and proprietary secrecy.
展开▼
